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I. General Information Materials and Methods
All commercial materials (Sigma Aldrich, Fisher, Acros, TCI, Adamas, J&K, GL Biochem, Energy, etc.) were used without further purification. All solvents were reagent grade or HPLC grade (Fisher, Sigma, Acros, Oceanpak). Anhydrous tetrahydrofuran, dichloromethane, diethyl ether, toluene, and N,N-dimethyl formamide were purified and dried by PURE SOLV ® solvent purification system (Innovative Technology, Inc.).
Analytical thin layer chromatography was performed using Merck TLC silica gel 60-F254 glass plates. Flash chromatography was performed using 200-300 mesh silica gel (Qingdao Haiyang Chemical Co., Ltd.). Filtration for crude peptide was performed using a Bulk GHP Acrodisc ® 13 mm syringe filter with 0.22 μm GHP membrane. Ultrapure argon (≥99.999%) was used in all ligation and desulfurization reactions. Yields refer to chromatographically and spectroscopically pure materials unless otherwise stated.
1 H NMR spectra were recorded on Bruker Avance III 400 MHz at ambient temperature using CDCl3 as solvent unless otherwise stated, referenced to TMS or residual solvent. 
II. Synthesis and Characterization of Penicillamine Derivative

Synthesis of the N-9-fluorenylmethoxycarbonyl-methylthio-L-penicillamine (2)
To a solution of penicillamine (300 mg, 2.0 mmol) in 15 mL of degassed EtOH was added methyl methanethiosulfonate (MMTS, 0.2 mL, 2.0 mmol) dropwise. The mixture was stirred at room temperature for 4 h. Upon the full consumption of penicillamine, the reaction was concentrated in vacuo to afford compound S1 without further purification.
To a solution of crude S1 and 9-fluorenylmethyl chloroformate (Fmoc-Cl, 624 mg, 2.4 mmol) in 15mL DCM, triethylamine (TEA, 0.67 mL, 4.8 mmol) was added dropwise at 0 °C. The reaction was stirred at room temperature under an argon atmosphere overnight, then quenched with 1 M aqueous HCl at 0 °C. The mixture was extracted three times with EtOAc, and the combined extracts were washed with H2O and brine, dried over magnesium sulfate, and concentrated in vacuo. The crude residue was purified using silica gel column chromatography eluting with petroleum ether/EtOAc 
Synthesis of (2S, 3R)-2-(tert-Butoxycarbonylamino)-4-(2-tret-Butyldisulfulfanyl)-Lvaline
Compound S2 was synthesized following literature reported procedures. S1 To the solution of methanesulfonyl chloride (77 µL, 1.0 equiv) and 2-methyl-2-propanethiol (0.11 mL, 1.0 equiv) in Et2O (1.0 mL) was added TEA (0.14 mL, 1.2 equiv) dropwise at 0 ˚C. The reaction was stirred at 0 ˚C for 30 min and then quenched with 1N HCl and water at 0 ˚C. The resulting mixture was extracted with ethyl acetate (×3), and the combined extracts were washed with water and brine, dried over MgSO4 and concentrated in vacuo. The crude material was purified using silica gel column chromatography (petroleum ether: CH2Cl2 = 5:1) to afford compound S2 as a colorless oil (150 mg, 90%).
A solution of compound S3 S2 (160 mg, 1.0 equiv) in methanol (3.7 mL) was treated with 1N NaOH solution (5.5 ml, 5.0 equiv) at 0˚C for 10 min. The reaction mixture was carefully neutralized using 1N HCl and water at 0˚C. The resulting mixture was extracted with ethyl acetate (×3). The combined extracts were washed with water and brine, dried with MgSO4 and concentrated in vacuo. The obtained crude intermediate was used directly in next step without purification, which was mixed with S2 (270 mg, S1 H. T. Pham, N.-L. T. Nguyen, F. Duus, T. X. T. Luu, Phosphorus, Sulfur, and Silicon and the Related Elements 2015 , 190, 1934 -1941 K. K. Pasunooti, R. Yang, B. Banerjee, T. Yap, C. F. Liu, Org. Lett. 2016 , 18, 2696 -2699 3.5 equiv) in anhydrous CH2Cl2 (3 mL), followed by the addition of TEA (80 µL, 1.2 equiv) at 0 ˚C. The reaction mixture was stirred at room temperature overnight, then quenched with 1N HCl and water at 0˚C. The resulting mixture was extracted with ethyl acetate (×3). The combined extracts were washed with water and brine, dried with MgSO4 and concentrated in vacuo to afford crude compound S4, which was treated with TFA/DCM = 9:1 (v/v) solution at room temperature for 2 hours. The solvent was removed under a nitrogen atmosphere. The residue was co-evaporated with toluene, and dissolved in 3 mL dioxane/H2O (1:1, v/v), followed by the addition of Boc2O (216 µL, 2.0 equiv) and TEA (80 µL, 1.3 equiv) at 0 ˚C. After stirring at room temperature for 24 hours, the reaction was quenched with 1N HCl and water at 0 ˚C. The resulting mixture was extracted with ethyl acetate (×3). The combined extracts were washed with water and brine, dried with MgSO4 and concentrated in vacuo. The crude residue was purified using silica gel column chromatography eluting with petroleum ether/EtOAc 155.6, 80.3, 57.3, 47.9, 43.8, 36.5, 29.9 
Determination of resin loading S4
Dry Fmoc amino-acid resin (approx. 5 μmol with respect to Fmoc) was weighted into a clean test tube, followed by the addition of 2 mL of 2% DBU in DMF. The mixture was agitated gently for 30 min, and then diluted to 10 mL with CH3CN. 2 mL of the resulting solution was taken out and diluted to 25 mL in a 50 mL centrifuge tube as the test solution. A reference solution was prepared in the same manner without the addition of resin.
Two matched silica UV cells were filled with reference solution to blank the U.V.
spectrophotometer. Fmoc loading: mmol/g = Abssample ×16.4/(mg of resin).
Automated solid-phase peptide synthesis
Automated peptide synthesis was performed on a Pioneer peptide synthesis system (GEN600611) or a CS Bio peptide synthesizer (CX136XT).
Pioneer peptide synthesizer Peptides were synthesized under standard automated Fmoc protocols using DMF as solvent, deblocking for 5 min in piperidine/DBU/DMF (2:2:96,
, coupling for 25 min ('standard cycle'), or 55 min ('extended cycle') for amino acids after steric hindered residues such as prolines, valines, threonines, isoleucines and arginines using HATU as coupling reagent.
CS Bio peptide synthesizer
Peptide synthesis was performed following the general protocol using DMF as solvent, deblocking (5 min × 2) in piperidine/ DMF (20:80, v/v) containing Oxyma (0.1 M), couple for 25 min using HATU/HOBt (1:1) as coupling reagent, for amino acids after steric hindered residues, the coupling cycle was repeated as needed. 
The employed 2-chlorotritylchloride resin (1.147 mmol/g) employed in SPPS was purchased from GL Biochem, and Rink MBHA resin (0.42 mmol/g) was purchased from CS Bio.
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Preparation of peptidyl acids and peptidyl amides
Upon completion of the automated synthesis on a 0.05 mmol scale, the peptide resin was washed into a peptide synthesis vessel using DCM. Resin cleavage and global deprotection was performed under the treatment of TFA/H2O/TIPS (95:2.5:
solution for 2 hours. The resin was then removed by filtration, and the filtrate was concentrated under a nitrogen atmosphere. The residue was washed with cold diethyl ether to give a white solid, which was then dissolved in a mixture of acetonitrile and water containing 5% of acetic acid. The resulting solution was ready for HPLC purification after filtration. Utilization of 2-chlorotrityl resin and Rink-MBHA resin afforded the peptidyl acids and peptidyl amides respectively.
For side-chain protected peptide, the resin after SPPS was treated with DCM/TFE/AcOH (3:1:1, v/v/v) solution 40 min (×3), the combined cleavage solution was concentrated under reduced pressure, and lyophilized to remove the residual acid.
Preparation of C-terminal Pen-Nbz containing peptides
Fmoc-Pen(SMe)-OH (2) (5.0 equiv) was coupled to pre-loaded Dbz-Rink-MBHA resin solution for 2 hours. The resin was then removed by filtration, and the filtrate was concentrated under a nitrogen atmosphere. The residue was washed with cold diethyl ether to give a white solid, which was then dissolved in a mixture of acetonitrile and water containing 5% of acetic acid. The resulting solution was ready for HPLC S13 purification after filtration.
Native Chemical Ligation
To a mixture of the west-side peptide (1.0 equiv), and east-side peptide containing thiolamino acid at the N-terminus (1.2 equiv), was added appropriate volume of ligation buffer (6 M Gn·HCl, 200 mM Na2HPO4, 20 mM TCEP·HCl, pH 7.0) under an argon atmosphere, the concentration of the west-side peptides is approximately 3 mM, and the resulting solution was stirred at room temperature (25 °C) and monitored using LC-MS. The reaction was quenched with H2O/MeCN/AcOH (90:5:5, v/v/v) and purified using HPLC.
Metal-free Desulfurization
To a solution of the thiol-containing peptide ( 
One-pot Ligation-Desulfurization
Upon completion of the ligation as indicated by LC-MS analysis, to the reaction vessel was added proper volume of 0.5 M Bond-breaker ® TCEP solution (Pierce), 20 μL of 2-methyl-2-propanethiol and 100 μL of radical initiator VA-044 (0.1 M in degassed water).
The reaction mixture was stirred at 37 °C and monitored by LC-MS. Upon completion, the reaction was quenched by adding H2O/MeCN/ AcOH (90:5:5, v/v/v) and further purified using HPLC.
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IV. Preparation and Characterization of Peptide Segments
Peptidyl Pen-Nbz 7a
Peptide 7a (mixture of 3-/4-substitued Nbz isomers) was prepared according to General Procedure 3.4 using Pioneer peptide synthesizer on a 0.03 mmol scale. Purification of the crude peptide using preparative HPLC (10 to 30% solvent B over 30min, Agilent
Eclipse XDB-C18 column) afforded peptide 7a as a white solid after lyophilization (11.1 mg, 45% 
Peptidyl Pen-Nbz 7b
Peptide 7b was prepared according to General Procedure 3.4 using Pioneer peptide synthesizer on a 0.02 mmol scale. Purification of the crude peptide using preparative HPLC (15 to 35% solvent B over 30min, Agilent Eclipse XDB-C18 column) afforded peptide 7b as a white solid after lyophilization (9.5 mg, 60% 
Peptidyl Pen-Nbz 7c
Peptide 7c (mixture of 3-/4-substitued Nbz isomers) was prepared according to General 
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Peptidyl Pen-Nbz 7d
Peptide 7d (mixture of 3-/4-substitued Nbz isomers) was prepared according to General Procedure 3.4 using Pioneer peptide synthesizer on a 0.02 mmol scale. Purification of the crude peptide using preparative HPLC (10 to 30% solvent B over 30min, Agilent
Eclipse XDB-C18 column) afforded peptide 7d as a white solid after lyophilization (10.9 mg, 59% 
peptidyl Val-Nbz 10
Peptide 10 (mixture of 3-/4-substitued Nbz isomers) was prepared according to General Procedure 3.4 using Pioneer peptide synthesizer on a 0.02 mmol scale. Purification of the crude peptide using preparative HPLC (10 to 30% solvent B over 30min, Agilent
Eclipse XDB-C18 column) afforded peptide 10 as a white solid after lyophilization (13.6 mg, 36% 
Peptidyl Cys-Nbz S7
Peptide S7 (mixture of 3-/4-substitued Nbz isomers) was prepared according to General S18 
Peptide 8a
Peptide 8a was prepared according to General Procedure 3.3 using CS Bio peptide synthesizer on a 0.05 mmol scale. Purification of the crude peptide using preparative HPLC (10 to 30% solvent B over 30min, Agilent Eclipse XDB-C18 column) afforded peptide 8a as a white solid after lyophilization (27.1 mg, 66% 
Peptide 8b
Peptide 8b was prepared according to General Procedure 3.3 using Pioneer peptide synthesizer on a 0.02 mmol scale. Purification of the crude peptide using preparative HPLC (10 to 30% solvent B over 30min, Agilent Eclipse XDB-C18 column) afforded peptide 8b as a white solid after lyophilization (13.6 mg, 36% 
Peptide 8c
Peptide 8c was prepared according to General Procedure 3.3 using Pioneer peptide S20 synthesizer on a 0.05 mmol scale. Purification of the crude peptide using preparative HPLC (10 to 30% solvent B over 30min, Agilent Eclipse XDB-C18 column) afforded peptide 8c as a white solid after lyophilization (11.2 mg, 41% 
Peptide 8d
Peptide 8d was prepared according to General Procedure 3.3 using Pioneer peptide synthesizer on a 0.05 mmol scale. Purification of the crude peptide using preparative HPLC (10 to 30% solvent B over 30min, Agilent Eclipse XDB-C18 column) afforded peptide 8d as a white solid after lyophilization (6.1 mg, 11% 
Peptide 8f
Peptide 8f was prepared according to General Procedure 3.3 using Pioneer peptide synthesizer on a 0.02 mmol scale. Purification of the crude peptide using preparative HPLC (10 to 30% solvent B over 30min, Agilent Eclipse XDB-C18 column) afforded peptide 8f as a white solid after lyophilization (4.5 mg, 28% 
Peptide 8g
Peptide 8g was prepared according to General Procedure 3.3 using Pioneer peptide synthesizer on a 0.05 mmol scale. Purification of the crude peptide using preparative HPLC (10 to 30% solvent B over 30min, Agilent Eclipse XDB-C18 column) afforded peptide 8g as a white solid after lyophilization (10.5 mg, 26% 
Peptidyl Pen-Nbz 7h
Peptide 7h was prepared according to General Procedure 3.4 using CS Bio peptide synthesizer on a 0.03 mmol scale. Purification of the crude peptide using preparative HPLC (25 to 35% solvent B over 30min, Proto-300 C4 column) afforded peptide 7h as a white solid after lyophilization (18.4 mg, 17% 
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Peptidyl thioester 13
Side-chain protected peptide Cys 34 -Pro 71 with Boc-protection at the N-terminus was synthesized using CS Bio peptide synthesizer on a 0.05 mmol scale. The resin was cleaved using DCM/TFE/AcOH (3:1:1, v/v/v) for three times (7 mL, 7 mL and 6 mL).
The filtrate was concentrated under an argon atmosphere, and lyophilized to remove the residual acid. To the obtained powder (1.0 equiv) was added leucine thioester (2.0 equiv) and HATU (2.0 equiv), and the mixture was dissolved in anhydrous DCM, followed by the addition of DIEA (4.0 equiv) at 0 °C. The reaction mixture was stirred at room temperature for 30 min. After removal of the solvent under a nitrogen atmosphere, the resulting residue was treated with a solution of TFA/H2O/TIPS (95:2.5:2.5, v/v/v) for 2 hours, and then concentrated under a nitrogen atmosphere. The residue was washed with cold diethyl ether to afford a white solid, which was then dissolved in a mixture of acetonitrile and water containing 5% of acetic acid. The resulting solution was ready for HPLC purification after filtration. Purification of the crude peptide using preparative HPLC (15 to 30% solvent B over 30min, Proto-300 C4 column) afforded peptide 13 as a white solid after lyophilization (23.6 mg, 10%). 
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Peptidyl thioester 19
Side-chain protected peptide Cys 36 -Leu 57 with Boc-protection at the N-terminus was synthesized using CS Bio peptide synthesizer on a 0.1 mmol scale. The resin was cleaved using DCM/TFE/AcOH (3:1:1, v/v/v) for three times (7 mL, 7 mL and 6 mL). 
Peptide 21
Peptide 21 was prepared according to General Procedure 3.3 using CS Bio peptide synthesizer on a 0.05 mmol scale, and the N-terminal thio-valine derivative was coupled manually using S5 (1.5 equiv) for 30 min (×2 
V. Ligation Reactions Probing the Mechanistic Insight
Ligation reactions between S6 and 8a
Peptidyl Val-Nbz S6 (1.0 equiv) and cysteinyl peptide 8a (1.2 equiv) were subjected to the ligation conditions following General Procedure 3.5 as described previously. The reaction was stirred at room temperature for 8 hours, and the progress was monitored with LC-MS. As shown in Figure S24 , a complex mixture was generated with low conversion to the ligation product after 8 h. 
Ligation reactions between S7 and 8a
Peptidyl Cys-Nbz S7 (1.0 equiv) and cysteinyl peptide 8a (1.2 equiv) were subjected to the ligation conditions following General Procedure 3.5 as described previously. The reaction was stirred at room temperature for 2 hours, and the progress was monitored with LC-MS. As shown in Figure S25 , large amount of S7 decomposed after 2 hours, and only trace amount of ligation product was generated. Figure S25 . UV trace of the ligation reaction between peptides S7 and 8a.
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Ligation reactions between 7a and S8
Peptidyl Pen-Nbz 7a (1.0 equiv) and alanyl peptide S8 (1.2 equiv) were subjected to the ligation conditions following General Procedure 3.5 as described previously. The reaction was stirred at room temperature for 8 hours, and the progress was monitored with LC-MS. As shown in Figure S26 , large amount of byproduct was generated and trace amount of ligation product was observed. Figure S26 . UV trace of the ligation reaction between peptides 7a and S8.
7a in ligation buffer
Peptidyl Pen-Nbz 7a (0.4 mg) was dissolved in 160 μL of ligation buffer, and monitored with LC-MS (5 to 30% B over solvent 30min, Agilent C18 column). As shown in Figure   S27 , the intermediate 7a' gradually decomposes and hydrolizes over time if not intercepted with other reactants. Figure S27 . UV trace of peptide 7a dissolved in ligation buffer.
S33
VI. One-Pot Ligation and Desulfurization Reactions
One-pot ligation and desulfurization reactions between 7a and 8a 0.70 mg of peptidyl Nbz 7a and 0.81 mg of cysteinyl peptide 8a were subjected to the ligation conditions following General Procedure 3.5 as described previously. The reaction was stirred for 2 h at room temperature, followed by the addition of Bond- 
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One-pot ligation and desulfurization reactions between 7a and 8f 0.68 mg of peptidyl Nbz 7a and 0.9 mg of cysteinyl peptide 8f were subjected to the ligation conditions following General Procedure 3.5 as described previously. The reaction was stirred for 2 h at room temperature, followed by the addition of Bond- 
One-pot ligation and desulfurization reactions between 7d and S9
0.83 mg of peptidyl Nbz 7d and 0.70 mg of cysteinyl peptide S9 were subjected to the ligation conditions following General Procedure 3.5 as described previously. The reaction was stirred for 8 h at room temperature, followed by the addition of Bondbreaker ® TCEP solution, t BuSH and VA-044 following General Procedure 3.7. The S40 reaction was stirred for another 3 h at 37 °C under an argon atmosphere, and quenched with 1.0 mL of CH3CN/H2O/AcOH (5/90/5) solution. As shown in Figure S35 , only trace amount of ligation and desulfurized products were observed, which failed to afford isolable amount of product after preparative HPLC purification. 
One-pot ligation and desulfurization reactions between 7h and 8h
3.9 mg of peptidyl Nbz 7h (1.0 equiv)and 4.7 mg of cysteinyl peptide 8h (1.5 equiv)
were subjected to the ligation buffer (6 M Gn·HCl, 200 mM Na2HPO4, 50 mM TCEP·HCl, pH 6.9) under an argon atmosphere, the concentration of the 7h is approximately 5 mM, and the resulting solution was stirred at room temperature for 8 Peptidyl Pen-Nbz 7h (2.6 mg, 1.0 equiv) and peptidyl thioester 13 (4.0 mg, 1.2 equiv)
were subjected to the ligation buffer (6 M Gn·HCl, 100 mM Na2HPO4, 100 mM sodium ascorbate, 50 mM TCEP·HCl, pH 7.5) under an argon atmosphere, the concentration of the 7h is approximately 5 mM, and the resulting solution was stirred for 8 h at room temperature. To the reaction mixture was then added a solution of 15b (2.2 mg, 1.5 equiv) in buffer containing MPAA. The reaction was stirred for another 8 hours at room temperature, and quenched with 1.0 mL of CH3CN/H2O/AcOH (5/90/5) solution. The resulting mixture was subjected to LC-MS analysis, and purified using preparative HPLC (25-33% solvent B over 30 min, Proto-300 C4 column 
Desulfurization of 16
Purified peptide 16 was subjected to desulfurization conditions following General Procedure 3.6 as described previously. The reaction mixture was allowed to stirred at 37 °C for 8 hours, and quenched with 1.0 mL of CH3CN/H2O/AcOH (5/90/5) solution.
The resulting mixture was subjected to LC-MS analysis, and purified using preparative HPLC (25-33% solvent B over 30 min, Proto 300-C4 column). The fractions containing pure peptide was concentrated affording 17 (2.2 mg, 31%, 3 steps) as a white solid.
Analytical HPLC for 17: tR = 25.6 min (20 to 40% solvent B over 30min, Proto-300 C4 
One-pot three segment ligation for the preparation of peptide 22
Peptidyl Pen-Nbz 18 (6.8 mg, 1.0 equiv) and peptidyl thioester 19 (5.0 mg, 1.2 equiv)
were subjected to the ligation buffer (6 M Gn·HCl, 100 mM Na2HPO4, 100 mM sodium ascorbate, 50 mM TCEP·HCl, pH 7.5) under an argon atmosphere, and the resulting solution was stirred overnight at room temperature. To the reaction mixture was then added a solution of 21 (5.9 mg, 1.4 equiv) in buffer containing MPAA. The reaction was stirred for another 8 hours at room temperature, and quenched with 1.0 mL of CH3CN/H2O/AcOH (5/90/5) solution. The resulting mixture was subjected to LC-MS analysis, and purified using preparative HPLC (27-38% solvent B over 30 min, Proto-300 C4 column). The fractions containing pure peptide was concentrated affording 22
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as a white solid with small amount of inseparable byproduct that could be removed in the next step. Analytical HPLC for 22: tR = 23.7 min (27 to 38% solvent B over 30min, 
Desulfurization of 22
Peptide 22 was subjected to desulfurization conditions following General Procedure 3.6
as described previously. The reaction mixture was allowed to stirred at 37 °C for 8 hours,
and quenched with 1.0 mL of CH3CN/H2O/AcOH (5/90/5) solution. The resulting mixture was subjected to LC-MS analysis, and purified using preparative HPLC (27-38% solvent B over 30 min, Proto 300-C4 column). The fractions containing pure peptide was concentrated affording 23 (5.0 mg, 35%, 3 steps) as a white solid. 
